Failure of anti-TNF therapy in TNF receptor 1-Associated periodic syndrome (TRAPS)

被引：75
作者：
Jacobelli, S.
Andre, M.
Alexandra, J.-F.
Dode, C.
Papo, T.
机构：
[1] Hop Xavier Bichat, Dept Internal Med, F-75018 Paris, France
[2] Gabriel Montpied Hosp, Dept Internal Med, F-63000 Clermont Ferrand, France
[3] Cochin Hosp, F-75014 Paris, France
来源：
RHEUMATOLOGY | 2007年 / 46卷 / 07期
关键词：
D O I：
10.1093/rheumatology/kel298
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1211 / 1212
页数：2
相关论文
共 50 条
  • [31] What is the risk of malignancies associated with anti-TNF therapy?
    Jonville-Bera, Annie-Pierre
    Lorette, Gerard
    PRESSE MEDICALE, 2009, 38 (09): : 1209 - 1210
  • [32] CLINICAL EFFICACY TO A SECOND ANTI-TNF THERAPY IS ASSOCIATED WITH THE DEVELOPMENT OF ANTIBODIES AGAINST THE FIRST ANTI-TNF THERAPY IN PATIENTS WITH SPONDYLOARTRHITIS
    Garcia Carazo, S.
    Plasencia, C.
    Pascual Salcedo, D.
    Bonilla Hernan, G.
    Lojo, L.
    Villalba, A.
    Nuno, L.
    del Olmo, L.
    Gil Barato, S.
    Alcocer Amores, P.
    Arribas, F.
    Perez, E.
    Martin Mola, E.
    Balsa, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 250 - 251
  • [33] Anti-TNF Levels in Cord Blood at Birth are Associated with Anti-TNF Type
    Kanis, Shannon L.
    de Lima-Karagiannis, Alison
    van der Ent, Cokkie
    Rizopoulos, Dimitris
    van der Woude, C. Janneke
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (08) : 939 - 947
  • [34] What is the best strategy after failure to anti-TNF? Ustekinumab or other anti-TNF?
    Cerpa Arencibia, A.
    Suarez Ferrer, C.
    Poza Cordon, J.
    Martin Arranz, E.
    Ramirez, L.
    Martin Arranz, M. D.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S554 - S554
  • [35] Onset of multiple sclerosis associated with anti-TNF therapy
    Sicotte, NL
    Voskuhl, RR
    NEUROLOGY, 2001, 57 (10) : 1885 - 1888
  • [36] Neurological adverse effects associated with anti-TNF therapy
    Ali, H. A.
    Shamin, S.
    Al-Bayati, M.
    Pace, A.
    RHEUMATOLOGY, 2007, 46 : I98 - I98
  • [37] OUTCOMES AND ECONOMIC IMPACT OF SWITCHING FROM ANTI-TNF TO ANTI-TNF THERAPY COMPARED WITH SWITCHING FROM ANTI-TNF TO VEDOLIZUMAB THERAPY IN PATIENTS WITH IBD
    Chiorean, Michael V.
    Afzali, Anita
    Zhou, Zhou
    Macaulay, Dendy
    Rizzo, Joanne
    Skup, Martha
    Wang, Anthony
    GASTROENTEROLOGY, 2017, 152 (05) : S591 - S591
  • [38] ECONOMIC IMPACT OF SWITCHING FROM ANTI-TNF THERAPY TO ADALIMUMAB, INFIXIMAB OR OTHER ANTI-TNF COMPARED WITH SWITCHING FROM ANTI-TNF THERAPY TO VEDOLIZUMAB
    Chiorean, Michael
    Afzali, Anita
    Cross, Raymond
    Zhou, Zhou
    Macaulay, Dendy
    Ganguli, Arijit
    Wang, Anthony
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S51 - S52
  • [39] Characterization of the TNFR1-d2 protein: Implication in TNF receptor associated periodic syndrome (TRAPS)?
    Rittore C.
    Sanchez E.
    Soler S.
    Ea V.
    Genevieve D.
    Touitou I.
    Grandemange S.
    Pediatric Rheumatology, 13 (Suppl 1)
  • [40] Genetic and functional studies of traps (TNF receptor associated periodic syndrome) knockin mice.
    Jackson, Adrianna J.
    Chae, Jae J.
    Raben, Nina
    Wood, Geryl
    Siegel, Richard M.
    Kastner, Daniel L.
    Komarow, Hirsh D.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S37 - S37
12345